Announcement under Regulation 30 (LODR)-Press Release / Media Release
Filed with BSE · ISIN INE194R01017 · · 4 pages · English
Summary by 6ix AI
Fredun Pharmaceuticals Ltd. has released its financial results for the first half of the fiscal year, highlighting significant growth in revenue and profit. Additionally, Fredun has made strategic acquisitions in the pet wellness sector, aiming to expand its product offerings and market presence.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Fredun Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Fredun Pharmaceuticals
- Approved The Proposal For Making An Application To National Stock Exchange Of India Limited (NSE) For Listing And Trading Of The Equity Shares Of The Company On NSE.
- Financial Results For The Quarter Ended 30Th September, 2026.
- Board Meeting Outcome for Outcome Of The Board Meeting
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement under Regulation 30 (LODR)-Allotment
Later from Fredun Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Follow Fredun Pharmaceuticals into a list and get an email when it puts out news.
Follow Fredun Pharmaceuticals